Expression and potential biological role of α(1,2)fucosylated glycotopes on amniotic and seminal fibronectins

2011 ◽  
Vol 39 (1) ◽  
pp. 355-359 ◽  
Author(s):  
Iwona Kątnik-Prastowska ◽  
Magdalena Orczyk-Pawiłowicz
Keyword(s):  
In Vitro Fertilization ◽  
Amniotic Fluid ◽  
Seminal Plasma ◽  
Potential Role ◽  
Biological Role ◽  
Vitro Fertilization ◽  
Infertile Men

The present paper describes concisely the expression and role of α(1,2)-linked fucose on some glycoconjugates as well as the detection, distribution and potential role of that glycotope on human soluble plasma and cellular fibronectins in addition to the expression on both normal and pathological amniotic fluid and seminal plasma fibronectins. The determination of α(1,2)fucosylated glycans is considered with respect to its usefulness as a potential clinically applicable biomarker in obstetrics to monitor pregnancy and in andrology to evaluate the ejaculate of infertile men and in vitro fertilization.

The epididymis and sperm maturation: a perspective

1993 ◽  
Vol 5 (4) ◽  
pp. 361 ◽  
Author(s):  
RP Amann ◽  
RH Hammerstedt ◽  
DN Veeramachaneni
Keyword(s):  
In Vitro Fertilization ◽  
Seminal Plasma ◽  
Normal Animal ◽  
Sperm Maturation ◽  
Vitro Fertilization ◽  
Cellular Changes ◽  
Probability Of Success ◽  
Epididymal Duct

In common mammals, sperm leaving the testis are incapable of fertilizing a female gamete. Sperm have limited biosynthetic capability and need to minimize demand for ATP. Hence, modification of sperm to achieve their maturation requires pre-programmed cleavage of integral molecules (planned self-modification) and remodelling by action of molecules found in the suspending fluids. Most of these biocatalysts are secreted by a series of specialized regions in the epididymal epithelium, but some are provided in seminal plasma. The role of the epididymis in sperm maturation is postulated to be 'setting a series of triggers' each capable of initiating cellular changes either at emission or near or in the oocyte, and 'setting a safety' for each trigger to prevent premature occurrence of the event. The attributes required in a spermatozoon for in vitro fertilization and natural mating are different, and their expression is dependent on the site of sperm sampling. Some attributes needed for fertility are probably like an on-off switch, whereas others probably allow a gradually reduced probability of success before going to the off position (analogous to a conventional light switch and a dimmer-type light switch). All essential attributes of a spermatozoon must be expressed in a 'combined effective amount' for that cell to be fertile. Because of mixing, in any segment of the epididymal duct the population of sperm is heterogeneous in age and biological status. Thus, when assessing sperm maturation it is necessary to establish the proportion of sperm that has completed and retained all steps of maturation necessary to achieve fertilization of oocytes under the conditions imposed. In a normal animal, most sperm leaving the epididymis have a 'combined effective amount' of attributes, and the population has a high fertilizing potential.

scholarly journals IN VITRO FERTILITY TEST OF HUMAN SPERMATOZOA MEMBRANE PROTEIN FERTILIN BETA ANTIBODY IN MICE (Mus musculus Balb/c) AS IMMUNOCONTRACEPTIVE CANDIDATE

2017 ◽  
Vol 52 (3) ◽  
pp. 209
Author(s):  
Reny I’tishom ◽  
Doddy M Soebadi ◽  
Aucky Hinting ◽  
Hamdani Lunardhi ◽  
Rina Yudiwati
Keyword(s):  
In Vitro Fertilization ◽  
Membrane Protein ◽  
Mus Musculus ◽  
Human Spermatozoa ◽  
Control Group ◽  
Reproductive Process ◽  
Vitro Fertilization ◽  
Antibody Induction

One of the materials as potential candidates immunocontraception material is spermatozoa. Fertilin beta is spermatozoa membrane protein and is found only in mature spermatozoa and ejaculate, which serves as an adhesion molecule. Spermatozoa membrane protein that is used as an ingredient immunocontraception candidate, must have specific criteria that the specificity of spermatozoa, the role of antigen in the fertilization process, which includes the formation of immunogenicity sufficient antibody response has the potential to block fertilization. Antibodies against spermatozoa affect the stages before fertilization of the reproductive process and can hinder the development of the embryo after fertilization. Until now very little research data spermatozoa membrane protein as an ingredient immunocontraception are up to the test of experimental animals. The research objective is to prove the role of the resulting antibody induction of antibodies fertilin beta protein in the membrane of human spermatozoa induce agglutination and reduce motility thus reducing the number of in vitro fertilization. Research conducted at the IVF Laboratory, Department of Biology of Medicine, Faculty of Medicine, University of Airlangga. This research includes: Test the potential of antibody protein beta fertilin membrane of human spermatozoa and inhibit the role of antibodies in vitro fertilization in mice (Mus musculus Balb/c). In vitro studies have resulted in fertilization figure of 25% is smaller than the number that is equal to control fertilization of 58.7%, whereas previously the spermatozoa were incubated first with a beta membrane protein antibody fertilin human spermatozoa. While the percentage of inhibition of sperm to fertilize an oocyte by 33.75%. Potential imunokontraseptif considered effective if it decreased significantly (P <0.05) than the numbers fertilization in the treatment group compared with the control group. This shows fertilin beta membrane protein antibody has the ability to inhibit human spermatozoa to fertilize oocytes that reduce the number of fertilization.

Sign in / Sign up

Export Citation Format

Share Document